Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 21, 2012

The Winner of GEN's Caption Contest Is...

The Winner of GEN's Caption Contest Is...

"Seymour, I know I told you to look for innovative ways at cutting our biohazardous waste stream, but this is not what I had in mind."

  • Thanks to all who participated in GEN's caption contest! The winning caption is:

    "Seymour, I know I told you to look for innovative ways at cutting our biohazardous waste stream, but this is not what I had in mind."

    The winner is Mark Stidham, Ph.D., executive director of government contracts administration at Trius Therapeutics. In addition to having his caption appear in GEN, he won $50. Congratulations, Dr. Stidham!

    Look for GEN's next caption contest, coming soon!



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »